Bortezomib

CAS 179324-69-7

Visão geral

Boltezomib is an anti-cancer drug used to treat multiple myeloma and mantle cell lymphoma. This includes those who have not been treated before and multiple myeloma. It is commonly used in combination with other drugs. It is given by injection

A Anant Labs fabrica e fornece impurezas de Bortezomib de alta qualidade para o mercado global. Nossas impurezas EP de Bortezomib são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.

Em Estoque

Bortezomib

Cat. No. ANTPRD4631Old No. ANT-BTZ-00CAS 179324-69-7Em Estoque

Dados Técnicos

New Cat. No.ANTPRD4631

Old Cat. No.ANT-BTZ-00

CAS179324-69-7

Fórmula Mol.C₁₉H₂₅BN₄O₄

Peso Mol.384.24 g/mol

IUPAC[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid

SMILESB([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O

InChIInChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1

Chave InChIGXJABQQUPOEUTA-RDJZCZTQSA-N

Sinônimos

[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acidBortezomib179324-69-7VelcadePS-341LDP-341NSC-681239LDP 341Bortezomib accord69G8BD63PP